Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

NYSE · Common stock

Trulieve Cannabis (TRLV)

$10.82 +$0.40 (+3.84%)

Day’s range
$10.24–$10.87
Volume
1.0M

TRLV price history

TRLV closed at $10.82 on Oct. 26, 2026. Over the past year, its daily close ranged from $8.06 on July 29, 2026 to $12.54 on Sept. 23, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $8 to $14, not from zero.
Data table: TRLV daily closes, the past year
TRLV daily closing prices, June 10, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$10.82
Oct. 23, 2026$10.42
Oct. 22, 2026$10.92
Oct. 21, 2026$11.00
Oct. 20, 2026$10.79
Oct. 19, 2026$10.28
Oct. 16, 2026$10.01
Oct. 15, 2026$10.30
Oct. 14, 2026$9.97
Oct. 13, 2026$10.11
Oct. 12, 2026$10.39
Oct. 9, 2026$10.67
Oct. 8, 2026$10.37
Oct. 7, 2026$10.78
Oct. 6, 2026$10.65
Oct. 5, 2026$10.65
Oct. 2, 2026$10.72
Oct. 1, 2026$10.87
Sept. 30, 2026$10.90
Sept. 29, 2026$12.41
Sept. 28, 2026$12.34
Sept. 25, 2026$12.21
Sept. 24, 2026$12.27
Sept. 23, 2026$12.54
Sept. 22, 2026$12.47
Sept. 21, 2026$11.50
Sept. 18, 2026$11.07
Sept. 17, 2026$11.65
Sept. 16, 2026$11.55
Sept. 15, 2026$11.60
Sept. 14, 2026$11.62
Sept. 11, 2026$11.31
Sept. 10, 2026$11.32
Sept. 9, 2026$11.77
Sept. 8, 2026$12.43
Sept. 4, 2026$12.11
Sept. 3, 2026$11.99
Sept. 2, 2026$11.69
Sept. 1, 2026$11.74
Aug. 31, 2026$11.51
Aug. 28, 2026$11.82
Aug. 27, 2026$11.03
Aug. 26, 2026$11.43
Aug. 25, 2026$11.32
Aug. 24, 2026$11.14
Aug. 21, 2026$11.10
Aug. 20, 2026$10.25
Aug. 19, 2026$10.09
Aug. 18, 2026$9.69
Aug. 17, 2026$9.47
Aug. 14, 2026$9.65
Aug. 13, 2026$9.60
Aug. 12, 2026$9.11
Aug. 11, 2026$9.30
Aug. 10, 2026$9.08
Aug. 7, 2026$8.75
Aug. 6, 2026$9.00
Aug. 5, 2026$8.44
Aug. 4, 2026$8.89
Aug. 3, 2026$8.60
July 31, 2026$8.65
July 30, 2026$8.57
July 29, 2026$8.06
July 28, 2026$8.33
July 27, 2026$8.33
July 24, 2026$8.36
July 23, 2026$8.55
July 22, 2026$8.67
July 21, 2026$8.96
July 20, 2026$8.76
July 17, 2026$8.79
July 16, 2026$8.41
July 15, 2026$8.63
July 14, 2026$9.06
July 13, 2026$9.04
July 10, 2026$8.62
July 9, 2026$8.84
July 8, 2026$8.89
July 7, 2026$8.93
July 6, 2026$8.82
July 2, 2026$9.78
July 1, 2026$9.54
June 30, 2026$9.83
June 29, 2026$9.24
June 26, 2026$8.99
June 25, 2026$8.52
June 24, 2026$8.50
June 23, 2026$8.53
June 22, 2026$9.12
June 18, 2026$10.10
June 17, 2026$9.45
June 16, 2026$9.40
June 15, 2026$9.86
June 12, 2026$10.35
June 11, 2026$11.55
June 10, 2026$11.50

Key figures

52-week range
—
Average daily volume
1.7MPast 3 months
Market value
$2.08B
Dividend yield
—
From 52-week high
—

Price change

1 month
−11.38%
3 months
+29.43%
Year to date
—
1 year
—

What Wall Street says about TRLV

In the past 90 days, Wall Street firms published 2 rating or price-target actions on TRLV: 2 reiterated ratings.

Rating and price-target actions on TRLV, past 90 days
ActionRating
Cantor FitzgeraldReiteratesOverweight$15
Cantor FitzgeraldReiteratesOverweight$15

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Trulieve Cannabis Corp.

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

Headquarters
Tallahassee, Fla.
Employees
5,000
Listed
Sept. 26, 2018
Sector
Materials
Industry
Medicinal chemicals & botanical products

trulieve.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about TRLV is on the site yet.

  • DFTXDefinium Therapeutics, Inc. Common Shares
  • CRONCronos Group Inc. Common Share
  • TLRYTilray Brands, Inc. Common Stock
  • CGCCanopy Growth Corporation Common Shares
  • USNAUSANA Health Sciences Inc
  • NAGENiagen Bioscience, Inc. Common Stock